Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

June 11, 2021
Policy News
Elute Receives FDA Authorization For Its First Clinical Trial Using Antibiotic Eluting Bone Void Filler

Elute has received an Investigational Device Exemption (IDE) authorization from the FDA to use its EP Granules with TobramycinTM in a pivotal clinical trial. This IDE investigates the use of a resorbable bone void filler that delivers a broad-spectrum antibiotic in the surgical treatment of bone infections following hip or knee replacements. This is the […]

June 11, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Renalytix Announces Leadership Additions for Expanding KidneyIntelX Deployment

RenalytixAI has announced a series of key hires to drive its commercialization strategy in the U.S. market in light of the recently announced Federal Government General Service Administration payment contract and additional large healthcare system partnerships. The combined background and experience of the new leadership team is expected to drive adoption of the KidneyIntelX testing […]

June 11, 2021
BioUtah News Utah's Life Sciences Companies
How St. George Became the Epicenter for a Major Global Genetics Study

The St. George Chamber of Commerce recently held a special luncheon with a presentation by Travis Sheffield, operations director for Intermountain Precision Genomics on “How St. George Became the Epicenter for a Major Global Genetics Study”. Sheffield, who is leading the HerediGene Population Study throughout Utah, Idaho, and soon in Nevada, presented the ins and […]

June 11, 2021
BioUtah News Industry News Life Sciences Industry News Utah's Life Sciences Companies
Altitude Lab Launches Investor Coalition to Fund and Mentor Healthcare Startups in Utah

On June 8, Altitude Lab has announced the launch of its Investor Coalition, a partnered network of leading healthcare venture capitalists to fund, mentor, and provide resources for Altitude-incubated startups. Together, the investor coalition aims to collectively invest $50 million in Altitude’s startups over the next three years, specifically supporting diverse and underrepresented founders. In […]

June 11, 2021
Policy News
Senate Passes Endless Frontiers Act to Boost U.S. Innovation

On Tuesday, the U.S. Senate passed the Endless Frontier Act to boost U.S. innovation and out-compete China. The bill passed the Senate by a vote of 68-32. The bill would provide $120 billion to the NSF, DOE and NASA to support research and develoopment in key technology areas critical to our national security, including biotechnology […]

June 9, 2021
Press Releases
BioUtah Statement on Launch of Altitude Lab’s Investor Coalition to Fund and Mentor Utah’s Life Sciences Startups

Salt Lake City – BioUtah President and CEO, Kelvyn Cullimore, issued the following statement upon the launch of Altitude Lab’s Investor Coalition to fund and mentor life sciences startups in Utah. BioUtah President and CEO, Kelvyn Cullimore, issued the following statement upon the launch of Altitude Lab’s Investor Coalition to fund and mentor life sciences […]

June 4, 2021
BioUtah News Industry News Utah's Life Sciences Companies
Scientia Raises $50M to Develop Devices for Stroke, Cancer Treatment

Scientia announced it has raised $50M in growth equity financing from Vivo Capital, a Palo Alto, CA-headquartered global healthcare investment firm. The financing will be used to accelerate sales, marketing, and new product development in both its core neurovascular stroke market as well as adjacent markets in peripheral vascular and interventional oncology. “We are excited […]

June 4, 2021
BioUtah News Economic Developments State News
Utah #1 For Best State Economic Outlook…Again

Utah has done it again! The 2021 “Rich States, Poor States” report recently released by the American Legislative Exchange Council (ALEC) ranks Utah as the state with the strongest economic outlook in the nation. Utah has held this first place designation for the past 14 years. View state-by-state data HERE. To determine its rankings, the […]

June 4, 2021
BioUtah News Industry News Utah's Life Sciences Companies
Utility Study Indicates KidneyIntelX Risk Assessment can Address Treatment Ambiguity in Primary Care

RenalytixA has announced results from a new utility study. The study confirms the importance of risk assessment testing in addressing treatment ambiguity in the early stages of diabetic kidney disease (DKD) and improving patient engagement and adherence – two major barriers to slowing or preventing DKD progression and preserving kidney health. In clinical studies, KidneyIntelX […]

June 4, 2021
BioUtah News
Known Medicine Shows Its BioHive Pride

Known Medicine is creating the world’s largest purpose-built 3D cell culture data set to predict the best drug for every cancer patient and create the best drug for every cancer. From patient tumor samples the company generates hundreds of micro-tumors on our proprietary platform and treat them with an extensive panel of drugs or drug […]

May 28, 2021
Policy News
House Democrats Urge HHS Secretary to Restore FDA Authority of COVID-19 Lab Developed Tests

Last August.under the Trump Administration, HHS announced that FDA would not have premarket review authority and oversight over laboratory developed tests (LDTs), including for COVID-19 tests and EUAs. Recently, House Energy and Commerce Committee Democrats sent a letter to HHS Secretary Becearra uring that he reverse the decision of the previous administration and reinstate FDA […]

May 28, 2021
BioUtah News Industry News Life Sciences Industry News
Turner Imaging Systems Receives CE Mark for Smart-C ® Mini C-Arm Portable Fluoroscopy X-Ray Imaging Device

Turner Imaging Systems has received its CE Mark for its Smart-C ® Mini C-Arm portable fluoroscopy x-ray imaging device. This will allow the Smart-C, the world’s first highly portable mini c-arm, to be distributed throughout the EU countries as well as the UK. “Securing the CE Mark is a critical regulatory milestone and major step […]

May 28, 2021
BioUtah News
Foldax Announces Successful First Human Use of Tria Biopolymer Mitral Heart Valve

Foldax has announced that it has successfully performed the first-in-man Tria Mitral Valve implant. This is another milestone for the Tria LifePolymer valve platform. Strategically, the mitral valve addresses an unmet global need for a more durable mitral valve that doesn’t require lifetime anticoagulants. This is especially important in the many areas where rheumatic fever […]

May 28, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Xenter, Inc. Continues Rapid Expansion with Appointment of Scott Heuler, SVP of Global Sales and Marketing, and Gary Baldwin as CTO

On the heels of last week’s announcement of the closing of its $12M Series A offering, Xenter, Inc. has announced the appointment of Scott Heuler as Senior Vice President of Global Sales & Marketing and Gary Baldwin as Chief Technology Officer in its Hospital Technologies business unit. Xenter is innovating new wireless technologies and techniques for […]

May 28, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Transit Scientific’s XO Score Scoring Sheath Platform Wins Medical Design Award

Transit Scientific”s XO Score Scoring Sheath Platform has been named a winner in the 2021 Medical Design Excellence Awards (MDEA). The MDEA is a premier design competition in the medtech industry, recognizing significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility. Recently, the company received European CE Mark […]

May 25, 2021
Policy News
Letter to Utah Congressional Delegation RE: H.R. 3, The Lower Drug Costs Now Act

Today, BioUtah, in conjunction with Centro Civico Mexicano, First Step House, International Cancer Advocacy Network, Mental Healthy FIT, Northern Utah Coalition, and Patel Family Investments, sent a letter to Utah’s congressional delegation expressing concern with the reintroduction of H.R. 3, The Lower Drug Costs Now Act. In the letter, the coalition states its concern about […]

May 20, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Transit Scientific’s Cutting-Edge Scoring Sheath Platform Earns CE Mark Approval

Transit Scientific has announced that its XO Score® Scoring Sheath Platform has received CE Mark clearance in the European Union for treatment of peripheral artery disease and end stage renal disease. Last year, the company announced FDA clearance for the device. We’ve been thrilled to see the effective low-pressure dilatation and luminal gain achieved using our […]

May 20, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Clene Nanomedicne Receives Healthy Longevity Catalyst Award

Clene Inc. announced on Monday that the company received a Healthy Longevity Catalyst Award from the U.S. National Academy of Medicine (NAM) to accelerate the preclinical development of CNM-Au8, a bioenergetic nanocatalyst, for treatment of neuronal aging-related deficits and Alzheimer’s disease. The international award will fund preclinical study of CNM-Au8 nanocatalysis for the improvement of human health […]

May 20, 2021
Policy News
CMS Again Delays Program to Expedite Coverage of Innovative Technologies

The Centers for Medicare & Medicaid Services (CMS) has once again delayed the January 14, 2021 final rule to establish the Medicare Coverage of Innovative Technology (MCIT) program. In a rule published in the federal register May 18, CMS further delays the effective date of the program to December 15, 2021. In issuing the rule, […]

May 14, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
ARUP Announces Partnership with TellBio for Use of TellBio’s Novel Circulating Tumor Cells Technology

ARUP Laboratories on May 10 announced it has signed a strategic agreement with Massachusetts-based TellBio Inc. to use the company’s TellDx circulating tumor cells (CTCs) technology in several research applications. ARUP has also invested in TellBio as part of the startup’s series A financing round. Other funding partners include Crocker Ventures, Genetron Holdings Ltd (NASDAQ: […]

May 14, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Xenter Closes Series A at $12M; Adds Four Additional Board Members

Xenter has announced the appointment of four additional industry leaders to its Board of Directors and the closing of a $12M Series A offering of preferred stock. “Xenter is transforming healthcare as an innovative Device-Data-Drug healthcare technologies startup,” said Kelvyn Cullimore, president and CEO of BioUtah. “The new additions to the board, including Utah life […]

May 14, 2021
Policy News
Who Develops Medicines? A New Study Highlights Role of Private Investment

Discussion around drug pricing often raises the issue of just how much NIH funding drives the development of new therapies. The general perception is that NIH funding is largely responsible for the creation and approval of new therapies. However, a new study by VitalTransformation (sponsored by BIO and PhRMA) finds that perception to be misguided. […]

May 14, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
IDbyDNA Appoints Next-Gen Sequencing Executive Neil Gunn as New CEO

IDbyDNA, the pioneer in precision metagenomics, has appointed Next-Generation Sequencing (NGS) leader Neil Gunn as its new CEO to drive the next phase of the company’s growth. “Having spent the last 12 years growing the PCR and sequencing businesses at Roche, I’m excited by the tremendous potential IDbyDNA’s platform has to transform the diagnostic approach to […]

May 14, 2021
Events
Webinar: From Utah the U.K.—Why Companies Should Consider an IPO on the London Stock Exchange

The webinar presented the opportunity for Utah companies to raise capital through an offering on London Stock Exchanges AIM platform

May 7, 2021
Policy News
House Energy and Commerce Committee Holds Hearing on Drug Price Controls

The House Energy and Commerce Health Subcommittee on Tuesday held a hearing on “Negotiating A Better Deal: Legislation to Lower the Cost of Prescription Drugs.”  All committee members called for legislation to lower drug costs, but differed along party line on how best to achieve that. House Democrats recently reintroduced H.R. 3, a sweeping drug pricing […]

May 7, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
SINTX Technologies Files Multiple New U.S. and International Patent Applications

This week SINTX Technoloiges announced multiple U.S. and international patent applications for development of new technologies utilizing the company’s silicon nitride. “The innovative application of SINTX’s silicon nitride promises new tools to improve our public health response to COVID-19 and other viruses,” said Kelvyn Cullimore, president and CEO of BioUtah. SINTX has found that its […]

May 7, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Foldax Named Among Fierce Medtech’s “Fierce 15” Companies of 2020

Foldax was named by Fierce Medtech as one of the 2020 “Fierce 15,” designating it as one of the most promising private companies in the medical technology industry. “BioUtah congratulates Foldax on this well-deserved recognition, which is all the more impressive amid the challenges of a pandemic,” said Kelvyn Cullimore, president and CEO of BioUtah. Foldax […]

May 7, 2021
COVID-19 Updates Policy News
Biden Supports IP Waiver for COVID-19 Vaccines

The Biden administration has announced that they will back a waiver of the WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement so that any country can produce vaccines without worrying about patent infringement. This has the potential to drastically hinder global vaccine manufacturing and distribution and sets a dangerous precedent for future pandemics. The […]

May 7, 2021
Events
Webinar: How to Monetize R&D Tax Credits

Many pre-revenue and pre-profit companies generate R&D Tax Credits. These tax credits can be monetized to offset employer payroll taxes as well as state and federal income taxes.

April 30, 2021
BioUtah News COVID-19 Updates Life Sciences Industry News Utah's Life Sciences Companies
Co-Diagnostics, Inc. JV CoSara Diagnostics Recognized for Work Combating COVID-19 Surge in India

Co-Diagnostics’ Indian manufacturing facility, CoSara Diagnostics Pvt. Ltd. (“CoSara,” or the “JV”, a Joint Venture with Synbiotics Ltd) has been featured in recent press highlighting its actions to provide COVID-19 diagnostics as a surge of infections has led to the world’s worst COVID-19 outbreak since the pandemic began. The article in the Times of India […]

April 30, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
U.S. Study of DiscGenics IDCT Achieves One-Year Follow-Up Milestone

DiscGenics, a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine,  has completed enrollment in its Japanese safety study of Injectable Discogenic Cell Therapy (IDCT) for lumbar disc degeneration, a major cause of chronic low back pain. This Japanese 38-subject […]

April 30, 2021
Policy News
Biden’s First Address to Congress Calls for Giving Medicare Power to Negotiate Drug Prices

President Joe Biden’s first major joint address to Congress on Wednesday included calls to give Medicare the power to negotiate drug prices. “Let’s give Medicare the power to save hundreds of billions by negotiating lower prices… we pay the highest drug prices of anywhere in the world right here in America,” Biden said.  BioUtah and other […]